CIK 0001708599
- Non-accelerated filer
- Smaller reporting company
Serina Therapeutics, Inc.
Sign in to watch- Ticker
- SER
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- AL
- Entity type
- Operating
- EIN
- 821436829
- Phone
- +1 256-327-9630
- Business address
- 601 GENOME WAY, SUITE 2001, HUNTSVILLE, AL, 35806
- Former names
- AgeX Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-17 | Venkatesan Jay Director | Conversion | +224,152 | $2.25 | $504K | 231,705 |
| 2026-06-17 | Venkatesan Jay Director | Grant or award · Stock Option (right to buy) | +15,250 | 15,250 | ||
| 2026-06-17 | Venkatesan Jay Director | Conversion · Series A Convertible Preferred Stock | −96,525 | $2.25 | $217K | 0 |
| 2026-05-22 | Venkatesan Jay Director | Purchase | +589 | $1.78 | $1K | 589 |
| 2026-03-31 | Venkatesan Jay Director | Grant or award | +7,553 | $1.94 | $15K | 7,553 |
| 2025-11-07 | Venkatesan Jay Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2025-04-08 | Venkatesan Jay Director | Grant or award · Series A Convertible Preferred Stock | +96,525 | $5.18 | $500K | 96,525 |
| 2025-02-12 | Venkatesan Jay Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 |
Page 1 of 1 · 8 trades